Sutro Biopharma, Inc. (S09.F)
Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
As of 03:29PM CEST. Market open.
| Previous Close | 3.0800 |
| Open | 3.1400 |
| Bid | 3.2800 x 0 |
| Ask | 3.4000 x 0 |
| Day's Range | 3.1400 - 3.1800 |
| 52 Week Range | 1.9100 - 5.4500 |
| Volume | |
| Avg. Volume | 40 |
| Market Cap | 270.041M |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Sutro Biopharma (STRO) Rises 9% in the Past Week: Here's Why
Sutro Biopharma (STRO) gains 9% in a week after initiating a phase II study on its lead candidate, luvelta, to treat FRa-expressing lung cancer.
- Simply Wall St.
Companies Like Sutro Biopharma (NASDAQ:STRO) Are In A Position To Invest In Growth
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
- Zacks
Sutro Biopharma, Inc. (STRO) Reports Q2 Loss, Lags Revenue Estimates
Sutro Biopharma (STRO) delivered earnings and revenue surprises of 22.37% and 2.18%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.